Clinical Trials Sponsored by Acceleron Pharma, Inc
Total 2368 results
-
Ocuphire Pharma, Inc.CompletedOcular Hypertension | Open Angle GlaucomaUnited States
-
Acasti Pharma Inc.CompletedAneurysmal Subarachnoid HemorrhageCanada
-
Ocuphire Pharma, Inc.CompletedMydriasis | DilationUnited States
-
aTyr Pharma, Inc.CompletedFacioscapulohumeral Muscular DystrophyUnited States, Italy, Netherlands
-
Sinew Pharma Inc.Completed
-
Ocuphire Pharma, Inc.Active, not recruiting
-
Yuyu Pharma, Inc.Active, not recruiting
-
Astellas Pharma IncCompletedLocally Advanced (Unresectable) or Metastatic Solid Tumor MalignanciesJapan
-
Ocuphire Pharma, Inc.CompletedDiabetic Retinopathy | Diabetic Macular Edema | NPDR - Non Proliferative Diabetic Retinopathy | PDR - Proliferative Diabetic RetinopathyUnited States
-
Akros Pharma Inc.CompletedDiabetes Mellitus, Type 2United States
-
Sinew Pharma Inc.TerminatedNASH - Nonalcoholic SteatohepatitisTaiwan
-
FSD Pharma, Inc.Terminated
-
Inversago Pharma Inc.Completed
-
OBI Pharma, IncCompletedMetastatic Colorectal Cancer | Metastatic Lung Cancer | Metastatic Breast Cancer | Metastatic Gastric CancerTaiwan
-
Astellas Pharma IncCompleted
-
Tris Pharma, Inc.CompletedDiabetic PolyneuropathyGermany, United Kingdom
-
Tris Pharma, Inc.TerminatedNeoplasms | Pain | Chronic PainCroatia, Austria, Belgium, Bulgaria, Denmark, Germany, Hungary, Poland, Romania, Serbia, Slovakia, Chile, Spain, United Kingdom
-
Inversago Pharma Inc.Completed
-
Astellas Pharma IncCompletedAdvanced Solid TumorsJapan
-
Beta Pharma, Inc.Completed
-
Cocrystal Pharma, Inc.Completed
-
Medexus Pharma, Inc.TerminatedHemophilia BUnited States, United Kingdom, India
-
Astellas Pharma IncCompletedArthritis, RheumatoidJapan, Korea, Republic of, Taiwan
-
Tris Pharma, Inc.CompletedAttention Deficit Disorder With HyperactivityUnited States
-
Astellas Pharma IncCompletedInterstitial Pneumonia Associated With Polymyositis/DermatomyositisJapan
-
Acanthas Pharma IncWithdrawnHealthy Volunteers
-
Astellas Pharma IncCompletedIrritable Bowel Syndrome With Constipation (IBS-C)Japan
-
Astellas Pharma IncCompletedOvarian Cancer | Solid TumorsUnited States, United Kingdom, Australia, Canada, Switzerland, Czechia, Italy, Poland, Romania, Russian Federation
-
Astellas Pharma IncCompletedAdvanced Solid TumorsUnited States, United Kingdom
-
Astellas Pharma IncCompletedRheumatoid Arthritis (RA)Japan
-
Tris Pharma, Inc.CompletedAttention Deficit Hyperactivity DisorderUnited States
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedType 2 Diabetes MellitusUnited States, Hungary, Poland, Romania, Italy, United Kingdom
-
Astellas Pharma IncCompletedType 2 Diabetes MellitusJapan
-
Astellas Pharma IncCompletedthe Maintenance Phase After Kidney TransplantationJapan
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedPatients With Impaired Renal FunctionJapan
-
Astellas Pharma IncCompletedLiver Transplantation | MycosesBelgium, France, Italy, Spain, Ireland, Germany, Portugal, Saudi Arabia, Austria, United Kingdom, Russian Federation, Hungary, Sweden, Romania
-
Astellas Pharma IncCompletedKidney TransplantationTaiwan, Korea, Republic of
-
Yuyu Pharma, Inc.CompletedOsteoporosisKorea, Republic of
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedRestless Legs Syndrome (RLS)Japan
-
Astellas Pharma IncCompletedNSCLC | Non Small Cell Lung CancerUnited States, Canada, Korea, Republic of, Singapore, Thailand, Hong Kong
-
Astellas Pharma IncCompletedAllogeneic Hematopoietic Cell TransplantJapan
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedPatients on Stable Chronic Maintenance Dialysis Who Are Receiving Hemodialysis Therapy | Pharmacodynamics of ASP7991 | Pharmacokinetics of ASP7991Japan
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncTerminatedEGFR-TKI-naïve Patients With NSCLC Harboring EGFR Activating MutationsJapan